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Interactions in diabetes <p>An integrative analysis combining genetic interactions and protein interactions can be used to identify candidate genes/proteins for  type 1 diabetes and other complex diseases.</p>
Abstract
We have developed an integrative analysis method combining genetic interactions, identified using
type 1 diabetes genome scan data, and a high-confidence human protein interaction network.
Resulting networks were ranked by the significance of the enrichment of proteins from interacting
regions. We identified a number of new protein network modules and novel candidate genes/
proteins for type 1 diabetes. We propose this type of integrative analysis as a general method for
the elucidation of genes and networks involved in diabetes and other complex diseases.
Background
Complex traits like type 1 diabetes (T1D) are generally
believed to be under the influence of multiple genes interact-
ing with each other to confer disease susceptibility and/or
protection. Identification of susceptibility genes in complex
genetic diseases, however, poses many challenging problems.
The contribution from single genes is often limited and
genetic studies generally do not offer clues about the func-
tional context of a gene associated with a complex disorder. A
recent report demonstrated the feasibility of constructing
functional human gene networks (using, for example, expres-
sion and Gene Ontology (GO) data [1]), and using these in pri-
oritizing positional candidate genes from non-interacting
susceptibility loci for various heritable disorders [2]. It was
shown that the obvious candidate genes were not always
involved, and that taking an unbiased approach in assessing
candidate genes using functional networks may result in new,
non-obvious hypotheses that are statistically significant.
One of the strongest indications of functional association is
the presence of a physical interaction between proteins [3]
and several reports have shown that proteins involved in the
same phenotype are likely to be part of the same functional
module (that is, protein sub-network) [4-6]. With this in
mind, it seems reasonable to expect that, in many cases, com-
ponents contributing to the same complex diseases will be
members of the same functional modules, especially if the
disease is associated with multiple genetic loci that show sta-
tistical indication for epistasis. This indicates that in the case
of complex disorders a feasible strategy would be to search for
groups of interacting proteins that together lead to significant
association with the disease in question. However, a strategy
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searching for loci showing genetic interaction (epistasis) inte-
grated with a search for protein networks spanning the epi-
static regions and subsequent significance ranking of these
networks has, to our knowledge, never been pursued for any
complex disorder.
Presumably, this is because a number of problems are associ-
ated with such a strategy. First, traditionally genetic linkage
analysis is performed by searching for the marginal effect of a
single putative trait locus, whereas methods for searching for
multiple trait loci simultaneously are limited [7-11], and in
T1D statistical indication for epistasis has been shown only
for a few candidate loci [10,12,13]. Secondly, an insufficient
amount of human protein interaction data has precluded sys-
tematic analyses of protein networks enriched for proteins
originating from interacting genomic regions. Moreover, no
single database houses all human protein interaction data,
and the data are generally noisy, containing many false posi-
tive interactions [4]. Thirdly, no standard statistical method
for measuring the significance of protein networks, based on
the enrichment of proteins from genetically interacting
regions, has yet been reported.
We addressed these issues through a number of approaches.
First, data mining/decision trees were used to identify genetic
markers or combinations of markers of predictive value for
T1D. This approach is well suited to handle the complexity of
genetic data, and has been proven to be able to precisely iden-
tify risk loci associated with T1D, as well as interacting genetic
regions [14-18]. In the present study we have tested whether
identical-by-descent (IBD) sharing data [19-21], instead of
exact allele-calling genotypes as previously used [18], could
be used to identify risk loci. The data analyzed were from the
published T1D genome scans [22,23] available through the
Type 1 Diabetes Genetics Consortium (T1DGC) [24]. We have
recently constructed a high-confidence human protein inter-
action network by extensive data integration, including con-
servative incorporation of data from model organisms,
followed by rigorous quality scoring of the protein interac-
tions [4]. This network was searched for protein networks
enriched in proteins from the interacting genetic regions
demonstrated. Subsequently, we developed a new statistical
method for evaluating the significance of this enrichment,
which enabled us to rank all identified networks. The strategy
used is outlined in Figure 1.
Several significant networks were identified. Some of the can-
didates in these networks were known HLA (human leuko-
cyte antigen) region (chromosome 6p21) genes, including the
recently identified T1D associated candidate gene ITPR3,
which was centrally located in one of the top scoring net-
works. However, some significant networks contained pro-
tein components that have never been associated with T1D.
Since all candidates identified in the present work were put in
a functional context with other members of a network (guilt-
by-association), the networks immediately offer clues on the
functional role of the candidates and other proteins in rela-
tion to T1D. Our observations support that genetic interac-
tions are important in T1D susceptibility, and that an
integration of genetic and physical interactions is an interest-
ing new approach for analyzing complex disorders.
Results
Marginal markers
In the total data set of 1,321 affected sibling pair families from
the UK, the US and Scandinavia, data mining/decision tree
analyses identified major T1D predictive signals (marginal
markers; Table 1) corresponding to T1D linkage signals found
by classic non-parametric linkage analysis [25]. As the origi-
nal T1DGC publication [25] included data on 254 additional
affected sibling-pair families not part of the present analyses,
direct comparison of results is not possible. However, sub-
stantial agreement existed between the analyses (Table 1).
Ranking of markers is according to their T1D predictive signal
determined by Pearson's χ2 statistics and corresponding P
value. As we evaluated only a limited number of the geno-
typed markers in the total data set, we endeavored to see if
supplementary information could be extracted from more
complete subsets of data (UK/US and Scandinavian). As seen
in Table 1, the group of markers corresponding to the HLA
region shows a much higher predictive signal (by several
orders of magnitude) than the rest of the markers. D6S283
and D6S300 are markers for IDDM15 (6q21) [26], which in
linkage studies generally require separate analysis to differ-
entiate its effect from MHC [25,26]. Markers for the regions
2q31-q33, 16p12-q11.1, 11p15.5, 16q22-q24 and 10p14-q11
identified by linkage analysis [25] also showed high predictive
signals in the current study, either in the total data set or in
the data subsets (Table 1). In addition, a few new markers
were found to show predictive signals (P < 0.05) when evalu-
ated independently of chromosome 6 markers, for example,
D17S798,  D2S125,  D9S175,  D8S261  and  D4S403. The
D21S270 marker was identified in the Scandinavian subset
and corresponds to a T1D linkage region on chromosome 21,
which we have recently identified and fine mapped [22,27]. In
the UK/US data set, the 2q31-q33 region (the CTLA4 region)
seems of higher predictive value than in the total data set
(Table 1). D4S403 corresponds to a region previously linked
to T1D [22,28] containing the WFS1 gene associated with
Wolfram syndrome (MIM #222300), which involves T1D
[28].
Epistasis
The importance of HLA is well established, and we are, by the
methods used here, able to evaluate important markers in
sibling pairs sharing just one HLA allele. The top scoring mar-
ginal marker for the HLA region was the tumor necrosis fac-
tor alpha (TNFA) micro satellite marker, located centrally in
the HLA region. To determine candidates for the next level,
we searched for interacting markers with the HLA region, in
the subgroups of sibling pairs with TNFA  IBD status = 1http://genomebiology.com/2007/8/11/R253 Genome Biology 2007,     Volume 8, Issue 11, Article R253       Bergholdt et al. R253.3
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The strategy used for the current study Figure 1
The strategy used for the current study.
Strategy
Genetic loci marker pairs showing
epistasis are identified using data
mining and decision trees on T1D
genome scan data from 1,321
affected sib pairs.
Identification of epistatic loci
Identification of enriched protein
subnetworks
Proteins from the epistatic regions
are extracted, and a high-
confidence human protein
interaction network containing more
than 72,000 interactions is scanned
for subnetworks enriched in
proteins from regions that show
epistasis.
Significance testing and ordering of
the enriched subnetworks
Significance of the enrichment of
proteins from epistatic regions are
calculated by random testing. The
networks are subsequently ordered
by significance to identify protein
pathways or complexes composed
of protiens from the epistatic
regions and putatively involved in
the epistasis of T1D. Hereby a
number of novel candidates and
functional insights to the
mechanisms of the disorder are
identified
TNFA - D4S403
TNFA - D2S177
.
.
.
TNFA - D1S229
TNFA D4S403 PPI networ k D1S229
P=1.1e-5 P=9.1e-4 P=1.1e-3Genome Biology 2007, 8:R253
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(TNFA = 1) and TNFA IBD status = 2 (TNFA = 2), respec-
tively. No interactions with TNFA = 0 could be generated due
to the low number of affected sibling pairs in this group. Spe-
cific combinations of markers corresponding to statistically
significant genetic interactions in the combined data set are
shown in Table 2. The marker combination TNFA  = 1 -
D11S910 was shown to be of protective value, since sibling
pairs sharing one TNFA allele, but two alleles of D11S910,
were strongly protected against T1D (of 25 sibling pairs with
this combination, one was concordant for T1D, 24 were non-
T1D). The other combinations of markers detected implied
increased susceptibility to T1D. None of the interacting mark-
ers from Table 2, except D4S403, correspond to previously
known regions associated with T1D [29].
Genetic interaction analysis was performed for the marginal
markers with the highest predictive signals, and was also per-
formed independent of HLA (TNFA) IBD sharing status.
When evaluating epistasis independent of HLA, we searched
specifically for epistasis between the three highest ranking
markers, D17S798, D2S152 and D2S125, after chromosome 6
markers were removed. In the combined data set, however,
only combinations including the marker on chromosome 17
predicted genetic interaction (that is, D17S798 = 1 - D5S429
(P  = 0.029) and D17S798  = 1 - D1S197  (P  = 0.031), and
between D17S798 = 2 - D2P25 (P = 0.041)). These combina-
tions reached statistical significance, and demonstrated
increased susceptibility to T1D (Table 2). Relationships could
only be inferred for two markers at a time due to the high
number of missing and non-informative values for many
markers.
Protein interaction networks
We searched for protein networks spanning the regions
shown to interact genetically (P values < 0.05; Table 2). This
was performed using a high-confidence human protein inter-
Table 1
Marginal markers. 
χ2 (2 d.f.) P value Position on
chromosome in cM
Confirmed from genome scan 
LOD - 1 interval) or other references
Total data set
TNFA 142.0 1.5 × 10-32 47 6p21 (46-48 cM) [25]
D6S273 77.0 7.0 × 10-18 45
D6S291 58.2 2.2 × 10-13 49.5
D6S276 34.8 3.4 × 10-8 44.4
D6S260 27.1 8.2 × 10-7 29.9
D6S286 21.4 1.6 × 10-5 89.8
D6S283 18.3 0.0001 109.2 [26]
D6S470 15.2 0.0005 18.2
D6S300 10.6 0.005 103.5 [26]
D17S798 9.8 0.007 53.4
D2S152 8.7 0.013 188.1 2q31-33 (177-204 cM) [25]
D2S125 7.0 0.03 260.6
D9S175 6.3 0.043 70.3
D8S261 6.1 0.048 37.0
D4S403 6.1 0.048 25.9
Selected markers
UK/US subset
D2S389 13.1 0.001 190 2q31-33 (177-204 cM) [25]
D16S769 9.4 0.009 50.6 16p12-q11.1 (26-71 cM) [25]
Th1 9.0 0.011 5.9 11p15.5 (0-14 cM) [25]
D16S289 8.1 0.017 105 16q22-q24 (100-121 cM) [25]
D10S183 6.7 0.035 60.6 10p14-q11 (52-66 cM) [25]
SCAND subset
D21S270 6.4 0.039 38.1 [27]
Markers of predictive value for T1D identified by decision tree analysis on T1D genome scan data from 1321 affected sib pair families. Markers 
identified in the total data set are ranked according to significance level (P < 0.05). Markers from data subsets are 'selected markers' and were 
selected on basis of whether they confirm loci from the latest T1D genome scan [25] or other references [26; 27]. D.f. = degrees of freedom.http://genomebiology.com/2007/8/11/R253 Genome Biology 2007,     Volume 8, Issue 11, Article R253       Bergholdt et al. R253.5
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action network [4]. Input proteins were proteins correspond-
ing to a defined genetic region surrounding the interacting
markers included in the different marker combinations. For
all markers except TNFA, 5 Mb on each side of the marker in
question was used as input. This region size was selected
since linkage peaks (LOD - 1 intervals) from genome scans
that use a similar number of markers often corresponded to
regions of this size. For the HLA region, we have exclusively
used the classic MHC region (4 Mb) for analysis, due to the
well examined nature of this region with a high degree of link-
age disequilibrium, as well as the large number of genes clus-
tered in this specific region [30]. The classic MHC region
comprises the TNFA marker in a central position (positioned
at bases 31,643,403-31,643,437 on the physical map of chro-
mosome 6, corresponding to 46.7 cM).
We were able to identify 22 protein sub-networks that con-
nect proteins from the different regions corresponding to the
significant two-marker predicted genetic interactions. The
union of these sub-networks resulted in 13 putative functional
modules (Figure 2).
Network significance analysis
The significance of each putative functional module was
assessed by comparison to search results for randomly
selected genetic regions. This assessment was made for both
the results of marker-region pairs (2-interval) and for the
resulting merged modules containing genes from two or more
intervals (k-interval). Four 2-interval modules that included
TNFA-region genes, two of which were found to be signifi-
cant, were merged into a single highly significant 5-interval
module (Figure 3, module A). This concordance strongly sug-
gests that the four TNFA-region genes TUBB, RPS18, ITPR3
and BAT1 may be important in explaining the mechanism of
the four genetic interactions. From the interacting chromo-
somal regions, the WDR1,  LMO7,  HNRPLL  and  RPS15A
genes are potential T1D candidate genes. These genes are
involved in transcriptional regulation, DNA binding, RNA
binding, ion channel activity, ATP synthesis, actin binding
and natural killer cell mediated cytotoxicity and cell prolifer-
ation. Candidate genes from the four significant functional
modules (Figure 3) are listed in Table 3. Other networks with
TNFA include genes involved in signal transduction, regula-
tion of transcription, protein biosynthesis and folding,
histone activity, ubiquitin-protein ligase activity, as well as
response to oxidative stress (Table 3), also of potential rele-
vance in T1D pathogenesis.
A region on chromosome 17 also conferred a high predictive
value for T1D and was found to have genetic interactions with
three other marker regions. Searches conducted for genes
from the three marker pairs (D17S798-D2P25,  D17S798-
D5S429 and D17S798-D1S197) resulted in six putative func-
tional modules after the initial results were combined (Figure
2). Several of the proteins in these networks are involved in
signal transduction, anti-apoptosis, RNA binding regulation
of transcription, kinase activity, oxidoreductase activity, DNA
and ATP binding as well as oxygen transporter activity (Table
3), making them potentially important in T1D pathogenesis.
One of these modules (Figure 3, module D) was found to be
significant (P  < 0.05) and contained protein interactions
between members of three genetic interaction marker pairs.
GO terms for molecular function and biological process for all
candidate genes in significant functional modules are listed in
Table 3. These findings shed light on the pathways the candi-
date genes in these two regions are likely to be involved in,
and may help in understanding the possible effect in T1D sug-
gested by this interaction.
Discussion
Identifying genes in multi-factorial diseases is difficult. Stud-
ies in model organisms suggest that epistasis may play an
important role in the etiology of multifactorial diseases and
Table 2
Statistically significant genomic interactions
First level Second level Pearson's χ2 (2 d.f.) P value
TNFA = 2 D4S403 9.10 0.011
TNFA = 2 D2S177 7.33 0.026
TNFA = 2 D1S229 6.88 0.032
TNFA = 1 D11S910 11.82 0.0027
TNFA = 1 D13S170 6.84 0.033
TNFA = 1 D16S287 6.63 0.036
D17S798 = 2 D2P25 6.41 0.041
D17S798 = 1 D5S429 7.08 0.029
D17S798 = 1 D1S197 6.94 0.031
Markers corresponding to the first and second level of each significant interaction, as well as Pearson χ2 statistics and corresponding P value, are 
shown. Affected sibling pairs (ASPs) genotyped for the TNFA and D17S798 marker were as follows (non-T1D sibling pairs were simulated to be 
twice the number of ASPs for each group): TNFA = 2, 520 ASP and 1,040 non-T1D sibling pairs; TNFA = 1, 206 ASP and 412 non-T1D sibling pairs; 
D17S798 = 2, 136 ASP and 272 non-T1D sibling pairs; D17S798 = 1, 254 ASP and 508 non-T1D sibling pairs.Genome Biology 2007, 8:R253
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complex traits in humans. There is no consensus as to the best
strategy for detecting epistatic interactions in humans
[31,32]. Several recent studies in humans and animals have
identified loci that interact significantly but contribute little
or with no effect individually [33-35]. In T1D, attempts to elu-
cidate possible epistasis between classic T1D loci in humans,
as well as animal models, have provided only a few examples
[10,12,13]. This highlights the need for new methods in
detecting and characterizing epistasis, as well as elucidating
the presumed underlying biological interactions [31,32]. In
the present study we confirmed that the application of data
mining methods identified most major signals (marginal
markers) found using classic non-parametric linkage analysis
[25]. A special feature of the methods used in the current
study is that interactions can be generated with marker IBD =
1 and IBD = 2 status. No marker combination with marker
IBD = 0 could be generated (due to a low number of affected
sibling pairs in this group).
We demonstrated several significant interactions between
two different markers predictive for increased susceptibility
to T1D and one rule (TNFA = 1 - D11S910), which predicted
protection against T1D. Generation of specific combinations
of markers between different chromosomal regions supports
that interaction is important in complex diseases like T1D. A
n u m b e r  o f  r e c e n t  e f f o r t s  h a v e  c o m b i n e d  l i n k a g e  m a p p i n g
with the identification of co-regulated genes using microar-
rays to discover trans-acting expression quantitative trait loci
[36-39]. While this may be a promising approach also for
identifying epistatic susceptibility genes in multifactorial dis-
eases like T1D, data for combined genetic and gene expres-
sion studies in T1D are still limited.
In our effort to identify the cellular systems underlying the
genetic interactions, we constructed protein sub-networks
that spanned the interacting regions to investigate whether
the gene products in these regions could be shown to physi-
Protein interaction networks for predicted genetic interactions Figure 2
Protein interaction networks for predicted genetic interactions. (a) TNFA-D4S403, TNFA-D13S170 and TNFA-D2S177 are represented by one network, 
whereas TNFA-D1S229, TNFA-D16S287 and TNFA-D11S910 are represented by two or three networks. Color-code: red, genes from TNFA region; green 
and yellow, genes from interacting region; light grey, genes from other chromosomes. (b) Protein interaction networks involving D17S798. D17S798-
D1S197, D17S798-D2P25 and D17S798-D5S429 are represented by four, three and two networks, respectively. Color-code: red, genes from D17S798-
region; blue/green, genes from interacting region; light grey, genes from other chromosomes.
TNFA
D11S910
D4S403
D16S287
D13S170
D2S177
D1S229
Genetic marker regions
D17S798
D5S429
D2P25
D1S197
Genetic marker
regions
(a) (b)http://genomebiology.com/2007/8/11/R253 Genome Biology 2007,     Volume 8, Issue 11, Article R253       Bergholdt et al. R253.7
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Table 3
Genes corresponding to protein interactions in the four statistically significant functional modules A, B, C and D (in Figure 3)
Gene name Chromosomal band Description GO term
Module A
DNAJC14 [12q13.2] Nuclear protein Hcc-1 (Proliferation associated 
cytokine-inducible protein CIP29)
Heat shock protein binding, unfolded protein binding
HNRPLL [2p22.1] Heterogeneous nuclear ribonucleoprotein L-like 
(Stromal RNA-regulating factor)
Nucleotide binding, RNA binding, mRNA processing
BAT1 [6p21.33] Spliceosome RNA helicase BAT1 (HLA-B associated 
transcript-1)
Nucleotide binding, nucleic acid binding, ATP-
dependent RNA helicase activity, nuclear mRNA 
splicing, mRNA export from nucleus, ATP 
biosynthetic process, ion transport
ITPR3 [6p21.31] Inositol 1,4,5-trisphosphate receptor type 3 Ion channel activity, calcium channel activity, calcium 
ion transport, protein binding, signal transduction
RPS18 [6p21.32] 40S ribosomal protein S18 (Ke-3) RNA binding, structural constituent of ribosome, 
rRNA binding, translation
TUBB [6p21.33] Tubulin beta-2 chain Nucleotide binding, GTPase activity, cell motility, 
natural killer cell mediated cytotoxicity
LMO7 [13q22.2] LIM domain only protein 7 (LOMP) (F-box only 
protein 20)
Protein ubiquination, actomyosin structure and 
biogenesis, protein binding, ion binding
WDR1 [4p16.1] WD repeat domain 1 (WDR1), transcript variant 1 Actin binding, protein binding, sensory perception of 
sound
RPS15A [16p12.3] 40S ribosomal protein S15a Protein binding, structural constituent of ribosome, 
translation
ELF5 [11p13] ETS-related transcription factor Elf-5 (E74-like factor 
5)
Transcription factor activity, sequence-specific DNA 
binding, regulation of transcription, cell proliferation
Module B
RDBP [6p21.3] RD RNA-binding protein, MHC complex gene RD RNA binding, nucleotide binding, transcription, 
regulation of transcription
GTF2H [2q14.3] Basic transcription factor 2 89 kDa subunit, DNA 
excision repair protein ERCC-3
DNA binding, ATP-dependent DNA helicase activity, 
transcription-coupled nucleotide-excision repair, 
regulation of transcription
RRN3 [16p13.11] RNA polymerase I-specific transcription initiation 
factor
RNA polymerase I transcription factor activity, 
regulation of transcription
ERCC4 [16p13.12] DNA excision repair protein, DNA repair 
endonuclease
DNA binding, magnesium ion binding, nucleotide 
excision repair
TAF1A [1q41] TATA box binding protein (TBP)-associated factor, 
RNA polymerase I
DNA binding, RNA polymerase I transcription factor 
activity, regulation of transcription
TYW3 [1p31.1] tRNA-yW synthesizing protein 3 homolog None
GUF1 [4p13] GTP-binding protein GUF1 homolog, GTPase of 
unknown function
Nucleotide binding, translation initiation factor 
activity, GTPase activity, small GTPase mediated 
activity
Module C
MOG [6p22.1] Myelin-oligodendrocyte glycoprotein precursor Synaptic transmission, central nervous system 
development
APLP2 [11q24.3] Amyloid-like protein 2 precursor (APPH) DNA binding, protein binding, G-protein coupled 
receptor protein signaling pathway
NTRI [11q25] Neurotrimin precursor (hNT) Protein binding, cell adhesion, neuron recognition
Module D
DDX52 [17q12] Probable ATP-dependent RNA helicase DDX52 
(DEAD box protein 52)
Nucleotide binding, ATP binding, ATP-dependent 
helicase activity
RPL23A [17q11.2] 60S ribosomal protein L23a Nucleotide binding, rRNA binding, translationGenome Biology 2007, 8:R253
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cally interact. The resulting networks were subsequently
statistically tested based on the significance of the enrich-
ment of proteins from interacting regions. After merging
results for common marker regions (TNFA and D17S798), it
was possible to identify four high-confidence protein interac-
tion sub-networks that were significantly enriched in proteins
from regions that interact, thereby supporting all nine epi-
static combinations identified. The constructed networks
point to specific candidates, and functional relationships
between the candidates. Further supporting the importance
of the most significant TNFA  functional module reported
here (Figure 2a), a recent paper mapped the ITPR3 gene in
the HLA region as a new candidate gene for T1D [40], since
strong genetic association was demonstrated in two Swedish
case-control cohorts.
Additionally, when all chromosome 6 markers were removed,
we inferred genetic interactions for regions on chromosomes
1, 2 and 5 interacting with a region on chromosome 17. A sin-
gle significant functional module resulted after combining
results from the three marker-pair searches that included
D17S798. This functional module implicated a physical inter-
action between one protein from all three associated regions
with a protein encoded by the RPL23A gene.
We hypothesize that the significant functional modules eluci-
dated in this current study represent critical steps in path-
ways of relevance in T1D pathogenesis. The identification of
known T1D associated genes supports the value of this
method in searching for yet unidentified genetic and func-
tional interactions involved in the pathogenetic processes
leading to complex genetic diseases.
Most of the genes encoding proteins of the functional module
networks have GO terms [1] (Table 3). However, most GO
terms for molecular function and biological processes relate
to each other in a simple manner and the current study sup-
ports that regulation of transcription and translation, signal
transduction, ATP binding, and DNA and RNA binding are of
relevance for beta-cell destruction in T1D pathogenesis
(Table 3). The functional implications for the protein-protein
interactions predicted strengthens the findings and high-
lights specific genes as candidates for further analysis. With
30% or more of human genes lacking functional annotation,
existing protein interaction databases and maps are still far
from being complete. Although many of the protein interac-
tions in databases have not been rigorously tested and
validated, in this work we applied very strict thresholds,
including only protein interactions that were supported by
various independent data sources. The functional modules
presented in this study also allow for the prediction of specific
candidate genes and proteins that may explain the nature of
the observed genetic interactions.
Conclusion
The data presented in the current study comprise, to our
knowledge, the most extensive genetic epistasis analysis in a
multifactorial disease (T1D) supported by protein interaction
networks. It is the first integration of genetic interactions with
a systematic search for physical protein interaction networks
significantly enriched in proteins from the interacting
regions. The results point to specific positional candidates
and cellular systems that may underlie disease susceptibility.
We believe the genetic interactions produced here and the
specific candidates and molecular systems highlighted by our
protein network analysis will lead to new insight into the
molecular pathology of T1D. Furthermore, we propose our
integrative analysis as a general method for the analysis of
genes and systems involved in various complex disorders.
Materials and methods
Genome scan data
The data set was generated by T1DGC as part of the combined
analysis of the existing T1D genome scans [22,23,25]. In this
NPM1 [5q35.1] Nucleophosmin (NPM) (Nucleolar phosphoprotein 
B23)
Transcription coactivator activity, RNA binding, 
intracellular protein transport, anti-apoptosis, 
response to stress
RPL26L1 [5q35.1] 60S ribosomal protein L26-like 1 Structural constituent of ribosome, translation
PRDX1 [1p34.1] Natural killer cell-enhancing factor A, Peroxiredoxin-
1
Oxidoreductase activity, peroxiredoxin, cell 
proliferation
RPS7 [2p25.3] 40S ribosomal protein S7 RNA binding, protein binding, translation
NGB [14q24.3] Neuroglobin Oxygen transporter activity, metal ion binding
FLOT1 [6p21.33] Flotillin 1, integral membrane component of caveolae Protein binding
SESN1 [6q21] Sestrin-1 (p53-regulated protein PA26) Response to DNA damage stimulus, cell cycle arrest, 
negative regulation of cell proliferation
SESN2 [1p35.3] Sestrin-2, hypoxia induced gene 95 (Hi95) Cell cycle arrest
Genes corresponding to protein interactions in the four statistically significant functional modules A, B, C and D (in Figure 3). Gene names, 
chromosomal bands, short descriptions and gene ontology terms (molecular function and biological process) are provided.
Table 3 (Continued)
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process all genotyping data were intra-familially recoded,
when possible, to show IBD status rather than exact allele
calls. The Scandinavian data set comprised 392 families (411
affected sibling pairs) that were genotyped for 335 microsat-
ellite markers. The combined UK/US data set included 763
families (910 affected sibling pairs) and genotyping of 1,283
markers. In order to analyze markers only genotyped in all
data sets the number of markers was reduced to 298. Thus,
the total data set used in the analysis comprised 1,321 affected
sibling pairs with genotyping data on 298 markers.
Data simulation for non-affected sibling pairs
As the total data set included only a few unaffected sibling
pairs and the analytical methods applied in the present study
take advantage of information from non-diseased subjects
[18], we simulated data for non-affected sibling pairs [14-
17,41]. A data matrix for unaffected sibling pairs was gener-
ated from the data matrix representing the affected sibling
pairs. For each marker the number of missing values from the
affected was maintained for unaffected sibling pairs. The rest
of the matrix for unaffected sibling pairs was completed with
values reflecting normal IBD 0, 1 and 2 frequencies, that is,
0.25, 0.5 and 0.25. No correction was made in the simulation
for the actual frequency of homozygous parents. The number
of unaffected sibling pairs (simulated) was two times the
number of affected sibling pairs. The final data matrix then
contained 1,311 affected sibling pairs and 2,622 non-affected
sibling pairs.
Analyses: marginal markers and interactions
Identification of marginal markers and evaluation of interac-
tion between markers were done as detailed previously [18],
with minor modifications. Briefly, data mining algorithms
and decision trees were used to predict the most informative
markers. We have used the concept of marginal markers and
the interactive tree model in SAS Enterprise Miner (SAS
Institute Inc., Cary, NC, USA) to calculate all marginal mark-
ers using Pearson's χ2 statistics and corresponding P value.
The tree algorithm determines marginal markers as the roots
(the highest level of the trees), as described previously [18].
The list of marginal markers identified by this method is pro-
duced by Pearson's χ2 statistics and corresponding P value.
When searching for interactions between a marginal marker
and markers on different chromosomes, we also used Pear-
son's χ2 statistics. Data sets were created including sibling
Significant functional modules (modules A-D) Figure 3
Significant functional modules (modules A-D). Straight lines represent validated protein-protein interactions, curved lines represent demonstrated genetic 
interactions (black bullets, predictive interactions; white bullets, protective interactions). Circles with gene names represent the gene encoding the protein 
of the interaction. Boxes are the marker regions shown to be involved in the genetic interactions and in which the genes are located.
Protein-protein interaction
Genetic interaction, susceptibility
Genetic interaction, protective
TNFA
D16S287
D13S170
D4S403
D1S229
TNFA
D16S287
D11S910
TNFA
D17S798
D2P25
D5S429
D1S197
D2S177
TNFA
TUBB
BAT1
ITPR3
RPS18
RDBP
GTF2H4
ERCC4
RRN3
TYW3
ELF5
GUF1
TAF1A
HNRPLL
DNAJC14
NTRI
APLP2
MOG
NPM1
RPL26L1
RPL23A
DDX52
PRDX1
SESN2
NGB
SESN1
FLOT1
RPS7
RPS15A
LMO7
WDR1
p=1.6x10-3
p=1.9x10-2
A
B
p=2.8x10-2
C
p=2.4x10-2
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pairs with TNFA IBD status = 1 (TNFA = 1), TNFA IBD status
= 2 (TNFA = 2), D17S798 IBD status = 1 (D17S798 = 1) and
D17S798 IBD status = 2 (D17S798 = 2) to search for interac-
tions between these, the highest ranked, marginal markers
and other markers. Pearson's χ2 statistics was then used to
search for association between T1D and a marker in these
individual data sets. Searching for interactions between
markers on the same chromosome was not performed,
because the random methods used here do not allow for link-
age disequilibrium of adjacent markers on a chromosome.
Human protein interaction networks
A human protein interaction network was generated [4].
Briefly, protein interaction data were obtained from the data-
bases BIND [42,43], MINT [44], IntAct [45], KEGG anno-
tated protein-protein interactions (PPrel), KEGG Enzymes
involved in neighboring steps (ECrel) [46] and Reactome pro-
teins involved in the same complex, indirect complex or same
or indirect reaction [47]. All human data were pooled, and to
increase information interolog data (protein interactions
among orthologous protein pairs in different organisms)
from 17 eukaryotic organisms were also included to obtain
protein-protein interaction networks [4]. We devised and
thoroughly tested a global confidence score for all interac-
tions in the network. This confidence score is constructed to
take into account factors like topology of the interaction net-
work surrounding the interaction, number of publications the
interaction had been detected in, that interactions are more
reliable, if they have been reproduced in more than one inde-
pendent interaction experiment, and, furthermore, the exper-
imental set-up (large- or small-scale study). Interactions
from large-scale experiments generally contain more false
positives than interactions from small-scale experiments
[48]. Furthermore, the reliability of this score was confirmed
by fitting a calibration curve of the score against overlap with
a high-confidence set of about 35,000 human interactions,
demonstrating that the score was a reliable measure of inter-
action confidence [4]. Networks were constructed from pro-
teins in defined intervals (corresponding to the respective
rules) and their first order interaction partners using inter-
olog data in a manner similar to that described by Lehner and
Fraser [49]. Proteins known to interact in other species were
mapped to their human orthologs using the Inparanoid data-
base [50,51]. In the resulting networks, each node represents
all proteins encoded by a single human gene and their
orthologs in other species. An edge between two nodes indi-
cates one or more interactions between any of the proteins
represented by the node. The protein interaction confidence
score was implemented to use only interaction data above the
interaction threshold separating 'high' from 'low' confidence
interaction data. This threshold was found by using a genetic
algorithm on the interaction network to obtain the optimal
threshold for signal to noise ratio [4].
To further reduce noise in the networks we also devised a net-
work score, implemented to retrieve sub-networks enriched
in proteins from the selected regions that interact directly or
through significant linker proteins (that is, proteins that con-
nect proteins from the selected regions, but are not in any of
the selected regions themselves). The network score reflects
the amount of interaction partners allowed for each linker
protein for it to be included in relation to the number of inter-
action partners from the selected regions. The score is calcu-
lated for every protein and is the result of 'number of
interactions with input proteins' divided by 'total interac-
tions' for each protein, making networks consisting of pro-
teins with many interactions less important and reducing
noise from highly interacting proteins from unselected
regions in the genome. A very stringent threshold-score of 0.5
was used.
Positional genes and their corresponding proteins were
obtained from the University of California Santa Cruz (UCSC)
genome browser using 'Genes and Gene Prediction Tracks'
[52] and 'Ensembl Genes' from the table browser [53]. For
two marker rules, proteins encoded by genes from 5 Mb on
each site of the respective markers were used as input pro-
teins. For the TNFA marker, proteins encoded by genes from
an interval corresponding to the classic MHC region (position
29.26-33.90 Mb on chromosome 6) [29] were used.
For each protein belonging to an interval of interest, a query
was made in the constructed human interaction network.
Only interactions above the high-confidence threshold were
maintained. Cytoscape version 2.3.1 was used to visualize the
resulting networks [54]. Genes were classified according to
GO terms [1].
Statistical assessment of functional modules
In an effort to determine the significance of the putative func-
tional modules, we empirically estimated the probability of
observing as many or more marker interval genes (ni and nj
for interval i and j) in modules of size N or smaller in our pro-
tein interaction network G, that is:
P(xi ≥ ni, xj ≥ nj, X ≤ N|G).
This probability was estimated for each module with ni > 0
and nj > 0 found for queries based on genes from one of the
nine 2-interval genetic interactions. Estimates were derived
from the size and number of modules discovered from
100,000 random queries. Random queries were constructed
from genes selected from random interval pairs with the same
number of genes as in the two genetically interacting marker
intervals. Random intervals were defined from consecutive
genes on a chromosome. As each query generates a varying
number of modules (connected components), the probability
estimates were calculated from the frequency of queries that
result in one or more connected components containing xi ≥
ni and xj ≥ nj genes from random interval i and j, respectively,
with total number of X ≤ N genes.http://genomebiology.com/2007/8/11/R253 Genome Biology 2007,     Volume 8, Issue 11, Article R253       Bergholdt et al. R253.11
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After merging all connected components from the nine differ-
ent 2-interval queries, six modules were found to contain
genes from three or more intervals. For each of these k-inter-
val modules, a new set of 100,000 random queries were per-
formed with k random intervals of the same sizes as the actual
intervals. Probabilities were estimated in the same way as
before but now based on gene counts from k intervals where
k ranged from 3 to 5.
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